A new method of generating mature nerve cells could greatly enhance understanding of neurodegenerative diseases such as Alzheimer's.
New research coming out of Cambridge University that could advance understanding of diseases such as Alzheimer’s or Parkinson’s is being commercialised by Cambridge Enterprise, Cambridge University’s technology transfer company. A company name for the spin-out was not announced.
Funded by the Medical Research Council and the Rosetrees Trust, the findings of the research, led by Anna Philpott from the Department of Oncology, will be published in the May 27 edition of the journal Development. The technique works by generating mature…
